In a 13-year-old boy with a posterior‑fossa medulloblastoma causing fourth‑ventricle obstruction and symptoms of headache, vomiting, dizziness, and fatigue, can surgical resection improve his condition?

Yes, Surgery is Essential and Should Be Performed Urgently

Surgical resection is the cornerstone of treatment for this 13-year-old boy with posterior fossa medulloblastoma causing fourth ventricle obstruction, and should be performed as soon as possible to relieve life-threatening hydrocephalus, reduce tumor mass effect, and obtain tissue for molecular classification that will guide subsequent therapy. 1

Primary Goals of Surgery

The surgical approach for this patient serves multiple critical purposes:

• Maximal safe resection while minimizing neurologic deficits - the goal is gross total resection (GTR) or near-total resection (NTR, defined as ≤1.5 cm² residual) 1
• Immediate relief of obstructive hydrocephalus - this addresses the acute symptoms of headache, vomiting, and dizziness caused by fourth ventricle obstruction 1
• Reduction of tumor-associated mass effect - debulking improves both immediate symptoms and long-term outcomes 1
• Obtaining adequate tissue for histopathologic diagnosis and molecular genetic characterization, which is essential for risk stratification and treatment planning 1

Why Surgery Improves Outcomes

The extent of surgical resection directly impacts survival and treatment efficacy. Suboptimal resection is associated with worse prognosis in medulloblastoma 1. The 2025 NCCN guidelines clearly distinguish between average-risk patients (who achieve GTR or NTR) and high-risk patients (who have subtotal resection), with different adjuvant therapy requirements 1.

Approximately 75% of children with medulloblastoma achieve prolonged survival with multimodality therapy that begins with surgical resection 1. Recent data shows that total resection is associated with improved survival outcomes 2.

Surgical Approach Considerations

For this specific case:

• CSF diversion may be needed acutely - either ventriculoperitoneal shunt or endoscopic third ventriculostomy are acceptable options to manage hydrocephalus 1
• Postoperative MRI should be obtained within 24-48 hours to confirm extent of resection 1
• Second-look surgery should be considered if resectable residual disease is identified on postoperative imaging 1

Critical Pitfalls to Avoid

Posterior fossa syndrome (cerebellar mutism) occurs in approximately 9% of cases, with medulloblastoma patients at higher risk (66% of mutism cases) 3. Midline tumors carry increased risk for both mutism and postoperative hydrocephalus 3.

Postoperative complications to monitor include:

• CSF leak (less common if preoperative shunt placed) 3
• Postoperative hydrocephalus (occurs in ~12% of cases) 3
• Respiratory and circulatory failure in the immediate postoperative period 4

What Happens After Surgery

Surgery is only the first step in a multimodal treatment algorithm. Following surgical resection and molecular characterization, this patient will require:

• Risk stratification based on molecular subgroup (WNT, SHH, Group 3, or Group 4), extent of resection, presence of metastases (M stage), and histology 1
• Adjuvant therapy consisting of craniospinal irradiation and chemotherapy, with intensity tailored to risk category 1
• Fertility preservation counseling before starting chemotherapy 1

The molecular subgroup significantly affects prognosis: WNT tumors have >90% long-term survival, while Group 3 tumors have only 20-30% 5-year survival rates 1.